Syncona (LON:SYNC) Given Buy Rating at Peel Hunt

Syncona (LON:SYNC)‘s stock had its “buy” rating restated by research analysts at Peel Hunt in a research report issued on Tuesday,Digital Look reports. They currently have a GBX 189 price target on the stock. Peel Hunt’s price objective suggests a potential upside of 77.63% from the company’s previous close.

Syncona Trading Down 0.4%

LON:SYNC opened at GBX 106.40 on Tuesday. Syncona has a 12 month low of GBX 86.80 and a 12 month high of GBX 109.80. The firm’s 50 day moving average is GBX 103.03 and its 200 day moving average is GBX 97.38. The stock has a market capitalization of £647.12 million, a PE ratio of -73.38 and a beta of 0.52.

Insider Buying and Selling at Syncona

In other news, insider John Roche purchased 16,063 shares of the business’s stock in a transaction dated Friday, June 19th. The stock was bought at an average price of GBX 100 per share, for a total transaction of £16,063. Insiders own 0.75% of the company’s stock.

Syncona Company Profile

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.